EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 133 filers reported holding EPIZYME INC in Q4 2021. The put-call ratio across all filers is 21.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $43,000 | -10.4% | 37,398 | +94.1% | 0.00% | – |
Q4 2021 | $48,000 | -52.0% | 19,264 | -0.9% | 0.00% | -100.0% |
Q3 2021 | $100,000 | -37.9% | 19,444 | +0.4% | 0.00% | 0.0% |
Q2 2021 | $161,000 | -10.6% | 19,368 | -6.4% | 0.00% | -50.0% |
Q1 2021 | $180,000 | -19.6% | 20,699 | +0.5% | 0.00% | 0.0% |
Q4 2020 | $224,000 | -12.2% | 20,600 | -3.5% | 0.00% | -33.3% |
Q3 2020 | $255,000 | -0.4% | 21,345 | +34.1% | 0.00% | -25.0% |
Q2 2020 | $256,000 | -3.4% | 15,921 | -6.9% | 0.00% | -20.0% |
Q1 2020 | $265,000 | – | 17,105 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |